The 2021 update additionally reports commonly altered genes in meningiomas, but largely does not use them as grading criteria with the exception of CDKN2A/B homozygous deletion and TERT promoter mutation as diagnostic for grade 3 meningiomas (23). The gene discussed is CDKN2A; the disease is meningioma.